CCNB1 and neoplasm: A study reports that circ-Ccnb1 suppresses mutant p53 by binding to H2AX and interacts with Ccnb1 and cyclin-dependent kinase 1 (Cdk1) proteins, resulting in the inhibition of tumor progression (43).